Lymph node status after resection for gallbladder adenocarcinoma: Prognostic implications of different nodal staging/scoring systems

Journal of Surgical Oncology

Volumn 111, Issue 3, 2015, Pages 299-305

  Amini, Neda ^a   Spolverato, Gaya ^a   Kim, Yuhree ^a   Gupta, Rohan ^a   Margonis, Georgios Antonios ^a   Ejaz, Aslam ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Gallbladder; Lymph node; Prognosis; Staging

Indexed keywords

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GALLBLADDER CARCINOMA; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SCORING SYSTEM; CANCER GRADING; FOLLOW UP; GALLBLADDER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84921988700     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23813     Document Type: Article

References (40)

1. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al.: Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 2001;51:349-364.
2. Wistuba II, Gazdar AF: Gallbladder cancer: Lessons from a rare tumour. Nat Rev Cancer 2004;4:695-706.
3. Randi G, Malvezzi M, Levi F, et al.: Epidemiology of biliary tract cancers: An update. Ann Oncol 2009;20:146-159.
4. Castro FA, Koshiol J, Hsing AW, et al.: Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site. Int J Cancer 2013;133:1664-1671.
5. Hueman MT, Vollmer CM Jr, Pawlik TM: Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol 2009;16:2101-2115.
6. Pawlik TM, Gleisner AL, Vigano L, et al.: Incidence of finding residual disease for incidental gallbladder carcinoma: Implications for re-resection. J Gastrointest Surg 2007;11:1478-1486;discussion 1486-1487.
7. Levy AD, Murakata LA, Rohrmann CA Jr: Gallbladder carcinoma: Radiologic-pathologic correlation. Radiographics 2001;21:295- 314;questionnaire, 549-555.
8. Mayo SC, Shore AD, Nathan H, et al.: National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: A population-based analysis. J Gastrointest Surg 2010;14:1578-1591.
9. Hari DM, Howard JH, Leung AM, et al.: A 21-year analysis of stage I gallbladder carcinoma: Is cholecystectomy alone adequate? HPB (Oxford) 2013;15:40-48.
10. Endo I, Shimada H, Tanabe M, et al.: Prognostic significance of the number of positive lymph nodes in gallbladder cancer. J Gastrointest Surg 2006;10:999-1007.
11. Shirai Y, Sakata J, Wakai T, et al.: Assessment of lymph node status in gallbladder cancer: Location, number, or ratio of positive nodes. World J Surg Oncol 2012;10:87.
12. Shirai Y, Wakai T, Hatakeyama K: Radical lymph node dissection for gallbladder cancer: Indications and limitations. Surg Oncol Clin N Am 2007;16:221-232.
13. Negi SS, Singh A, Chaudhary A: Lymph nodal involvement as prognostic factor in gallbladder cancer: Location, count or ratio? J Gastrointest Surg 2011;15:1017-1025.
14. Benoist S, Panis Y, Fagniez PL: Long-term results after curative resection for carcinoma of the gallbladder. French University Association for Surgical Research. Am J Surg 1998;175:118-122.
15. Kim WS, Choi DW, You DD, et al.: Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg 2010;14:679-687.
16. Oh TG, Chung MJ, Bang S, et al.: Comparison of the sixth and seventh editions of the AJCC TNM classification for gallbladder cancer. J Gastrointest Surg 2013;17:925-930.
17. Liu GJ, Li XH, Chen YX, et al.: Radical lymph node dissection and assessment: Impact on gallbladder cancer prognosis. World J Gastroenterol 2013;19:5150-5158.
18. Edge SB, Compton CC: The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010;17:1471-1474.
19. Sakata J, Shirai Y, Wakai T, et al.: Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol 2010;17:1831-1840.
20. Wang J, Hassett J, Dayton M, et al.: The prognostic superiority of log odds of positive lymph nodes in stage III colon cancer. J Gastrointest Surg 2008;12:1790-1796.
21. Sun Z, Xu Y, Li De M, et al.: Log odds of positive lymph nodes: A novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection. Cancer 2010;116:2571-2580.
22. Gleisner AL, Mogal H, Dodson R, et al.: Nodal status, number of lymph nodes examined, and lymph node ratio: What defines prognosis after resection of colon adenocarcinoma? J Am Coll Surg 2013;217:1090-1100.
23. Surveillance E, And End Results (Seer) Program (Www.Seer.Cancer.Gov Seer-Stat Database: Incidence - Seer 9 Regs Research Data, Nov 2011 Sub (1973-2010). To County Attributes - Total U.S., 1969-2010 Counties, National Cancer Institute, Dccps, Surveillance Research Program, Surveillance Systems Branch, Released April 2013, Based on the November 2012 Submission.
24. Fritz AG: International classification of diseases for oncology: ICDO 2000.Geneva, Switzerland: World Health Organization.
25. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Amer Statis Assoc 1958;53:457-481.
26. Harrell F, Lee KL, Mark DB: Tutorial in biostatistics multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
27. Yamaoka K, Nakagawa T, Uno T: Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165-175.
28. De Jong MC, Nathan H, Sotiropoulos GC, et al.: Intrahepatic cholangiocarcinoma: An international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29:3140-3145.
29. Deng JY, Liang H: Clinical significance of lymph node metastasis in gastric cancer. World J Gastroenterol 2014;20:3967-3975.
30. Miki J, Egawa S: The role of lymph node dissection in the management of prostate cancer. Int J Clin Oncol 2011;16:195-202.
31. Okholm C, Svendsen LB, Achiam MP: Status and prognosis of lymph node metastasis in patients with cardia cancer-A systematic review. Surg Oncol 2014.
32. Greene FL, Page Dl, Fleming Id: AJCC cancer staging manual, Vol. 1. New York: Springer. 2002.
33. Wang X, Appleby DH, Zhang X, et al.: Comparison of three lymph node staging schemes for predicting outcome in patients with gastric cancer. Br J Surg 2013;100:505-514.
34. Persiani R, Cananzi FM, Biondi A, et al.: Log odds of positive lymph nodes in colon cancer: A meaningful ratio-based lymph node classification system. World J Surg 2012;36:667-674.
35. Aurello P, Petrucciani N, Nigri G, et al.: Log odds of positive lymph nodes (LODDS): What are their role in the prognostic assessment of gastric adenocarcinoma? J Gastroint Surg 2014;18:1254-1260.
36. Pilgrim C, Groeschl R, Turaga K, et al.: Key factors influencing prognosis in relation to gallbladder cancer. Dig Dis Sci 2013;58: 2455-2462.
37. Jensen EH, Abraham A, Habermann EB, et al.: A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg 2009;13:722-727.
38. Fetzner UK, Holscher AH, Stippel DL: Regional lymphadenectomy strongly recommended in T1b gallbladder cancer. World J Gastroenterol 2011;17:4347-4348.
39. Choi BG, Kim CY, Cho SH, et al.: Impact of lymph node ratio as a valuable prognostic factor in gallbladder carcinoma, focusing on stage IIIB gallbladder carcinoma. J Korean Surg Soc 2013;84: 168-177.
40. Nathan H, Pawlik TM: Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol 2008;15:415-423.